IRIS
FALCIANI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.089
EU - Europa 7.570
AS - Asia 3.746
SA - Sud America 635
AF - Africa 187
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.250
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.972
GB - Regno Unito 1.638
RU - Federazione Russa 1.473
CN - Cina 1.354
IT - Italia 1.252
SG - Singapore 1.055
IE - Irlanda 875
SE - Svezia 535
BR - Brasile 505
UA - Ucraina 449
DE - Germania 435
VN - Vietnam 390
FR - Francia 347
HK - Hong Kong 286
KR - Corea 212
FI - Finlandia 202
IN - India 121
ZA - Sudafrica 107
ES - Italia 89
CA - Canada 63
PL - Polonia 60
BD - Bangladesh 58
BE - Belgio 54
AR - Argentina 45
NL - Olanda 39
PK - Pakistan 34
TR - Turchia 33
JP - Giappone 31
MX - Messico 29
IR - Iran 25
AT - Austria 22
CZ - Repubblica Ceca 20
VE - Venezuela 18
EC - Ecuador 17
NG - Nigeria 17
CL - Cile 16
IQ - Iraq 16
CH - Svizzera 15
KE - Kenya 15
AU - Australia 14
AZ - Azerbaigian 12
ID - Indonesia 12
PH - Filippine 12
UZ - Uzbekistan 12
LT - Lituania 11
CO - Colombia 10
IL - Israele 10
KZ - Kazakistan 10
PE - Perù 10
RO - Romania 10
TN - Tunisia 10
DZ - Algeria 9
JO - Giordania 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
EG - Egitto 7
CI - Costa d'Avorio 6
DK - Danimarca 6
EU - Europa 6
PY - Paraguay 6
BY - Bielorussia 5
DO - Repubblica Dominicana 5
EE - Estonia 5
NP - Nepal 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
LA - Repubblica Popolare Democratica del Laos 4
OM - Oman 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
GY - Guiana 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
SI - Slovenia 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
GR - Grecia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 20.238
Salva come PNG Salva come JPEG
Città #
Southend 1.445
Dallas 974
Dublin 866
Fairfield 662
Ashburn 601
Singapore 581
Chandler 481
Moscow 421
Siena 419
Jacksonville 363
Santa Clara 359
Beijing 346
Woodbridge 341
Ann Arbor 297
San Jose 285
Houston 273
Wilmington 270
Seattle 268
Hong Kong 266
Hefei 263
Menlo Park 234
Cambridge 211
Seoul 209
Los Angeles 148
Princeton 143
New York 128
The Dalles 122
Council Bluffs 117
Nanjing 112
Milan 107
Johannesburg 100
Ho Chi Minh City 98
Florence 91
Helsinki 87
Munich 86
Lauterbourg 82
Dong Ket 81
Boardman 76
Hanoi 70
Málaga 60
Rome 59
Shanghai 59
San Mateo 54
Nanchang 49
Buffalo 48
São Paulo 47
San Diego 45
Fremont 40
London 39
Brussels 38
Orem 38
Bengaluru 36
Dearborn 34
Turku 32
Warsaw 32
Hebei 30
Shenyang 30
Redwood City 28
Brooklyn 26
Chicago 26
Tianjin 26
Düsseldorf 24
Kunming 24
Columbus 23
Phoenix 23
Da Nang 22
Frankfurt am Main 22
Montreal 22
Redondo Beach 22
Tokyo 22
Toronto 22
Washington 22
Bagno a Ripoli 21
Stockholm 20
Lappeenranta 19
Chennai 18
Porto Alegre 18
Abuja 17
Brno 17
Dhaka 17
Belo Horizonte 16
Denver 16
Jiaxing 16
Amsterdam 15
Atlanta 15
Changsha 15
Manchester 15
Nuremberg 15
Paris 15
Poplar 15
Rio de Janeiro 15
San Francisco 15
Gdansk 14
Vienna 14
Brasília 13
Hangzhou 13
Izmir 13
Kansas City 13
Ningbo 13
Zhengzhou 13
Totale 13.643
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 372
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 362
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 357
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 353
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 335
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 323
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 318
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 309
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 306
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 300
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 300
A new NT4 peptide-based drug delivery system for cancer treatment 300
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 298
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 297
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 291
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 283
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 283
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 282
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 276
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 274
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 272
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 272
Tumor imaging with tetrabranched neurotensin 267
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 264
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 262
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 261
Branched peptides as bioactive molecules for drug design 259
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 257
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 256
Branched peptides for tumor diagnosis and therapy 248
Branched Neurotensin For Tumor Targeting 247
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 246
Bioactive peptides from libraries 241
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 241
Exploration of novel thiobarbituric acid- rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors 240
Branched peptides as targeting agents for tumor imaging and therapy 237
Nanoparticles exposing neurotensin tumor-specific drivers 236
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 232
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 230
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 228
Branched Neurotensin peptides for tumor personalized therapy 225
Branched multimeric peptides for tumor diagnosis and therapy 221
Synthetic peptides in the form of dendrimers become resistant to protease activity 220
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 220
A Multidisciplinary Approach for the Identification ofNovel HIV-1 Non-Nucleoside Reverse TranscriptaseInhibitors: S-DABOCs and DAVPs 219
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 218
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 217
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 212
Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles 211
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 209
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 207
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 206
The antimicrobial peptide M33. An example of drug development 206
Branched neurotensin for tumor targeting 205
The development of antimicrobial peptides as new antibacterial drugs 204
Tumor selective targeting by branched peptides 200
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 198
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 197
Molecular basis of branched peptides resistance to enzyme proteolysis 197
Neurotensin-derived branched peptides and uses thereof 192
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 191
Are periodontitis and psoriasis associated? A pre-clinical murine model 190
Branched peptides as therapeutics 186
Characterization of the branched antimicrobial peptide M6 by analyzing its mechanism of action and in vivo toxicity. 183
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 179
Synthetic antidotes against snake neurotoxins 173
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 170
The antimicrobial peptide M33. An example of drug development 167
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 165
Branched neurotensin peptides for tumor targeting 162
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 161
Tumor imaging with tetrabranched neurotensin 161
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 159
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 157
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 155
Dendrimeric peptides for tumor targeting 155
Oligo-branched peptides for tumor targeting: From magic bullets to magic forks 155
Branched peptides as novel tumor-targeting agents for bladder cancer 152
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection 150
The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide 143
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 143
Synthetic inhibitors of anthrax lethal toxin 139
Synthetic peptides in the form of dendrimers can become resistant to protease activity 139
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 137
Extracellular Vesicles of Pseudomonas: Friends and Foes 134
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 134
Structurally driven selection of human hepatitis C virus mimotopes. 124
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 117
Peptide Drugs 113
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 111
null 105
Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer 89
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 86
null 78
Establishment and application of a vesicle extraction method for clinical strains of Pseudomonas aeruginosa 66
A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis 66
Totale 20.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.387
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021605 0 0 0 0 0 0 0 0 0 285 131 189
2021/20221.246 77 122 79 132 85 51 51 77 48 151 127 246
2022/20231.766 94 186 217 226 188 337 41 145 142 82 79 29
2023/20241.406 45 41 125 81 61 392 489 29 7 27 18 91
2024/20252.895 56 130 330 173 351 157 119 188 221 118 297 755
2025/20266.489 530 936 819 880 1.370 258 741 227 312 416 0 0
Totale 20.494